The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Open accessAbstract
In Wuhan, China, a novel and alarmingly contagious primary atypical (viral) pneumonia broke out in December 2019. It has since been identified as a zoonotic coronavirus, similar to SARS coronavirus and MERS coronavirus and named COVID-19. As of 8 February 2020, 33 738 confirmed cases and 811 deaths have been reported in China. Here we review the basic reproduction number (R0) of the COVID-19 virus. R0 is an indication of the transmissibility of a virus, representing the average number of new infections generated by an infectious person in a totally naïve population. For R0 > 1, the number infected is likely to increase, and for R0 < 1, transmission is likely to die out. The basic reproduction number is a central concept in infectious disease epidemiology, indicating the risk of an infectious agent with respect to epidemic spread. PubMed, bioRxiv and Google Scholar were accessed to search for eligible studies. The term ‘coronavirus & basic reproduction number’ was used. The time period covered was from 1 January 2020 to 7 February 2020. For this time period, we identified 12 studies which estimated the basic reproductive number for COVID-19 from China and overseas. Table 1 shows that the estimates ranged from 1.4 to 6.49, with a mean of 3.28, a median of 2.79 and interquartile range (IQR) of 1.16. Published estimates of R0 for 2019-nCoV CI, Confidence interval. Published estimates of R0 for 2019-nCoV CI, Confidence interval. Timeline of the R0 estimates for the 2019-nCoV virus in China The first studies initially reported estimates of R0 with lower values. Estimations subsequently increased and then again returned in the most recent estimates to the levels initially reported (Figure 1). A closer look reveals that the estimation method used played a role. The two studies using stochastic methods to estimate R0, reported a range of 2.2–2.68 with an average of 2.44.1,9 The six studies using mathematical methods to estimate R0 produced a range from 1.5 to 6.49, with an average of 4.2.2,4–6,8,10 The three studies using statistical methods such as exponential growth estimated an R0 ranging from 2.2 to 3.58, with an average of 2.67.3,7,11 Our review found the average R0 to be 3.28 and median to be 2.79, which exceed WHO estimates from 1.4 to 2.5. The studies using stochastic and statistical methods for deriving R0 provide estimates that are reasonably comparable. However, the studies using mathematical methods produce estimates that are, on average, higher. Some of the mathematically derived estimates fall within the range produced the statistical and stochastic estimates. It is important to further assess the reason for the higher R0 values estimated by some the mathematical studies. For example, modelling assumptions may have played a role. In more recent studies, R0 seems to have stabilized at around 2–3. R0 estimations produced at later stages can be expected to be more reliable, as they build upon more case data and include the effect of awareness and intervention. It is worthy to note that the WHO point estimates are consistently below all published estimates, although the higher end of the WHO range includes the lower end of the estimates reviewed here. R0 estimates for SARS have been reported to range between 2 and 5, which is within the range of the mean R0 for COVID-19 found in this review. Due to similarities of both pathogen and region of exposure, this is expected. On the other hand, despite the heightened public awareness and impressively strong interventional response, the COVID-19 is already more widespread than SARS, indicating it may be more transmissible. This review found that the estimated mean R0 for COVID-19 is around 3.28, with a median of 2.79 and IQR of 1.16, which is considerably higher than the WHO estimate at 1.95. These estimates of R0 depend on the estimation method used as well as the validity of the underlying assumptions. Due to insufficient data and short onset time, current estimates of R0 for COVID-19 are possibly biased. However, as more data are accumulated, estimation error can be expected to decrease and a clearer picture should form. Based on these considerations, R0 for COVID-19 is expected to be around 2–3, which is broadly consistent with the WHO estimate. J.R. and A.W.S. had the idea, and Y.L. did the literature search and created the table and figure. Y.L. and A.W.S. wrote the first draft; A.A.G. drafted the final manuscript. All authors contributed to the final manuscript. None declared. Teaser: Our review found the average R0 for COVID-19 to be 3.28, which exceeds WHO estimates from 1.4 to 2.5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Self-citationReport 3: Transmissibility of 2019-nCoV
Imai, N., Cori, A., Dorigatti, I., Baguelin, M., Donnelly, C., Riley, S., & Ferguson, N. (2020) · Imperial College London · doi:10.25561/77148 · Cited by 210
Research works printed but not linked: 8
- Wu, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study, 10.1016/S0140-6736(20)30260-9 · DOI · Paper page
- Shen, 2020, Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China, bioRxiv
- Liu, 2020, Transmission dynamics of 2019 novel coronavirus (2019-nCoV), bioRxiv
- Read, 2020, Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions, medRxiv
- Majumder, 2020, Early transmissibility assessment of a novel coronavirus in Wuhan, China, 10.2139/ssrn.3524675 · DOI
- Cao, 2020, Estimating the effective reproduction number of the 2019-nCoV in China, 10.1101/2020.01.27.20018952 · DOI
- Zhao, 2020, Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a datadriven analysis in the early phase of the outbreak, bioRxiv
- Riou, 2020, Pattern of early human-to-human transmission of Wuhan 2019-nCoV, bioRxiv
Cited by
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Pan, A., Liu, L., Wang, C., Guo, H., Hao, X., Wang, Q., Huang, J., He, N., Yu, H., Lin, X., et al. (2020) · JAMA · doi:10.1001/jama.2020.6130 · Cited by 1,931
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
Liu, K., Chen, Y., Lin, R., & Han, K. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.005 · Cited by 1,642
Cheung, K. S., Hung, I. F. N., Chan, P. P. Y., Lung, K. C., Tso, E., Liu, R., Ng, Y. Y., Chu, M. Y., Chung, T. W. H., Tam, A. R., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.065 · Cited by 1,631
Airborne transmission of respiratory viruses
Wang, C. C., Prather, K. A., Sznitman, J., Jimenez, J. L., Lakdawala, S. S., Tufekci, Z., & Marr, L. C. (2021) · Science · doi:10.1126/science.abd9149 · Cited by 1,543
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis
Deng, J., Zhou, F., Hou, W., Silver, Z., Wong, C. Y., Chang, O., Huang, E., & Zuo, Q. K. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14506 · Cited by 771
Chu, H., Chan, J. F.-W., Yuen, T. T.-T., Shuai, H., Yuan, S., Wang, Y., Hu, B., Yip, C. C.-Y., Tsang, J. O.-L., Huang, X., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30004-5 · Cited by 748
Evolution and epidemic spread of SARS-CoV-2 in Brazil
Candido, D. S., Claro, I. M., de Jesus, J. G., Souza, W. M., Moreira, F. R. R., Dellicour, S., Mellan, T. A., du Plessis, L., Pereira, R. H. M., Sales, F. C. S., et al. (2020) · Science · doi:10.1126/science.abd2161 · Cited by 573
Solomou, I., & Constantinidou, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17144924 · Cited by 591
“However, the rapidly forming situation of the COVID-19, the rate of transmission, and the number of people infected in over 150 countries, to date, created an unprecedented situation of global proportions [2,3].”
BackgroundHuman mobility restrictions and the spread of the Novel Coronavirus (2019-nCoV) in China
(2020) · doi:10.1016/j.jpubeco.2020.104272 · Cited by 603
Machine learning-based prediction of COVID-19 diagnosis based on symptoms
Zoabi, Y., Deri-Rozov, S., & Shomron, N. (2021) · npj Digital Medicine · doi:10.1038/s41746-020-00372-6 · Cited by 523
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
Boettler, T., Newsome, P. N., Mondelli, M. U., Maticic, M., Cordero, E., Cornberg, M., & Berg, T. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100113 · Cited by 477
Ye, Z., Yang, X., Zeng, C., Wang, Y., Shen, Z., Li, X., & Lin, D. (2020) · Applied Psychology Health and Well-Being · doi:10.1111/aphw.12211 · Cited by 478
The benefits and costs of using social distancing to flatten the curve for COVID-19
Thunström, L., Newbold, S. C., Finnoff, D., Ashworth, M., & Shogren, J. F. (2020) · Journal of Benefit-Cost Analysis · doi:10.1017/bca.2020.12 · Cited by 439
Lau, H., Khosrawipour, T., Kocbach, P., Ichii, H., Bania, J., & Khosrawipour, V. (2021) · Pulmonology · doi:10.1016/j.pulmoe.2020.05.015 · Cited by 335
Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1754293 · Cited by 293
Sanghera, J., Pattani, N., Hashmi, Y., Varley, K. F., Cheruvu, M. S., Bradley, A., & Burke, J. R. (2020) · Journal of Occupational Health · doi:10.1002/1348-9585.12175 · Cited by 274
Robotics Utilization for Healthcare Digitization in Global COVID-19 Management
Khan, Z. H., Siddique, A., & Lee, C. W. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113819 · Cited by 281
Billah, M. A., Miah, M. M., & Khan, M. N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0242128 · Cited by 260
Badawy, S. M., & Radovic, A. (2020) · JMIR Pediatrics and Parenting · doi:10.2196/20049 · Cited by 242
Castellini, G., Cassioli, E., Rossi, E., Innocenti, M., Gironi, V., Sanfilippo, G., Felciai, F., Monteleone, A. M., & Ricca, V. (2020) · International Journal of Eating Disorders · doi:10.1002/eat.23368 · Cited by 223
Robotics and artificial intelligence in healthcare during COVID-19 pandemic: a systematic review
Sarker, S., Jamal, L., Ahmed, S. F., & Irtisam, N. (2021) · Robotics and Autonomous Systems · doi:10.1016/j.robot.2021.103902 · Cited by 199
Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19
Sun, S., Folarin, A. A., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., Cummins, N., Matcham, F., Dalla Costa, G., Simblett, S., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/19992 · Cited by 256
The duration of infectiousness of individuals infected with SARS-CoV-2
Walsh, K. A., Spillane, S., Comber, L., Cardwell, K., Harrington, P., Connell, J., Teljeur, C., Broderick, N., de Gascun, C. F., Smith, S. M., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.10.009 · Cited by 157
Shipping markets in turmoil: An analysis of the Covid-19 outbreak and its implications
Michail, N. A., & Melas, K. D. (2020) · Transportation Research Interdisciplinary Perspectives · doi:10.1016/j.trip.2020.100178 · Cited by 162
Gozzi, N., Tizzoni, M., Chinazzi, M., Ferres, L., Vespignani, A., & Perra, N. (2021) · Nature Communications · doi:10.1038/s41467-021-22601-6 · Cited by 142
Alquisiras-Burgos, I., Peralta-Arrieta, I., Alonso-Palomares, L. A., Zacapala-Gómez, A. E., Salmerón-Bárcenas, E. G., & Aguilera, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02134-7 · Cited by 115
The origin and early spread of SARS-CoV-2 in Europe
Nadeau, S. A., Vaughan, T. G., Scire, J., Huisman, J. S., & Stadler, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012008118 · Cited by 93
Biosurfactants: A COVID-19 Perspective
Smith, M. L., Gandolfi, S., Coshall, P. M., & Rahman, P. K. S. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01341 · Cited by 96
Current Status of COVID-19 Therapies and Drug Repositioning Applications
Altay, O., Mohammadi, E., Lam, S., Turkez, H., Boren, J., Nielsen, J., Uhlen, M., & Mardinoglu, A. (2020) · iScience · doi:10.1016/j.isci.2020.101303 · Cited by 98
Chen, J., He, H., Cheng, W., Liu, Y., Sun, Z., Chai, C., Kong, Q., Sun, W., Zhang, J., Guo, S., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101816 · Cited by 66
Self-citationPsychological Impact of COVID-19 Confinement and Its Relationship with Meditation
Jiménez, Ó., Sánchez-Sánchez, L. C., & García-Montes, J. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186642 · Cited by 63
Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities
Yaqinuddin, A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110049 · Cited by 55
(2020) · Journal of Clinical Psychiatry · doi:10.5505/kpd.2020.59862 · Cited by 41
Cegolon, L., Mirandola, M., Salaris, C., Salvati, M. V., Mastrangelo, G., & Salata, C. (2021) · Pathogens · doi:10.3390/pathogens10020233 · Cited by 30
Predicting COVID-19 Spread from Large-Scale Mobility Data
Schwabe, A., Persson, J., & Feuerriegel, S. (2021) · Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining · doi:10.1145/3447548.3467157 · Cited by 26
Kamel, M. S., El-Sayed, A. A., Munds, R. A., & Verma, M. S. (2023) · Animals · doi:10.3390/ani13030524 · Cited by 12
Metadata
- Authors
- Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J.
- Venue
- Journal of Travel Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02-13
- Volume
- 27
- Issue
- 2
- ISSN
- 1195-1982 (ISSN-L)
- 1708-8305
- OpenAlex
- W3006642361
- Cited by
- 3,192
- References
- 2
- FWCI
- 117.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
